Patients with the mutations tended to survive longer and had tumors more susceptible to aggressive treatment.
Breast cancer patients with groups of mutations clustered in their genome have better outcomes than patients without them, researchers found in a recent study.
More than half of breast cancer patients have clusters of genetic mutations called kataegis, and their cancer tends to be less invasive, offering better opportunities for effective treatment, according to researchers at the University of California San Diego.
 |
| Although researchers are unsure of how the clusters of genetic mutations called kataegis occur, but cancer patients who have them in tumors tend to respond better to treatment and have better outcomes, according to a recent study. |
Source: cigdem/Shutterstock
